Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.
Watkins JM, Zauls AJ, Kearney PL, Shirai K, Ruppert BN, Harper JL, Sherman CA, Aguero EG, Reed CE, Sharma AK. Watkins JM, et al. Among authors: sherman ca. Jpn J Clin Oncol. 2011 Mar;41(3):334-42. doi: 10.1093/jjco/hyq208. Epub 2010 Nov 17. Jpn J Clin Oncol. 2011. PMID: 21084436
Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
Watkins JM, Wahlquist AE, Shirai K, Garrett-Mayer E, Aguero EG, Fortney JA, Sherman CA, Sharma AK. Watkins JM, et al. Among authors: sherman ca. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1108-13. doi: 10.1016/j.ijrobp.2008.09.013. Epub 2008 Dec 10. Int J Radiat Oncol Biol Phys. 2009. PMID: 19084345
Once-daily radiotherapy to > or =59.4 Gy versus twice-daily radiotherapy to > or =45.0 Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes.
Watkins JM, Fortney JA, Wahlquist AE, Shirai K, Garrett-Mayer E, Aguero EG, Sherman CA, Turrisi AT 3rd, Sharma AK. Watkins JM, et al. Among authors: sherman ca. Jpn J Radiol. 2010 Jun;28(5):340-8. doi: 10.1007/s11604-010-0429-x. Epub 2010 Jun 30. Jpn J Radiol. 2010. PMID: 20585921
Locally advanced esophageal cancer.
Sherman CA, Turrisi AT, Wallace MB, Reed CE. Sherman CA, et al. Curr Treat Options Oncol. 2002 Dec;3(6):475-85. doi: 10.1007/s11864-002-0067-3. Curr Treat Options Oncol. 2002. PMID: 12392637 Review.
Irinotecan in the management of patients with pancreatic cancer.
Green MR, Harper M, Safa A, Sherman CA, Mushtaq CM, Bahadori H, Brescia FJ, Rocha Lima CM. Green MR, et al. Among authors: sherman ca. Oncology (Williston Park). 2000 Dec;14(12 Suppl 14):31-3. Oncology (Williston Park). 2000. PMID: 11200146 Free article. Review.
53 results